Found 132 of ic50 data for polymerid = 50004118 TargetUbiquitin-like modifier-activating enzyme 1(Homo sapiens (Human))
Millennium Pharmaceuticals, Inc.
US Patent
Millennium Pharmaceuticals, Inc.
US Patent
Affinity DataIC50: 10nMAssay Description:The UAE enzymatic reaction totals 50 μL and contains 50 mmol HEPES (pH 7.5), 0.05% BSA, 2.5 mM MgCl2, 0.1 uM ATP, 8 nM GST-Ubc-2, 35 nM flag-ubi...More data for this Ligand-Target Pair
TargetUbiquitin-like modifier-activating enzyme 1(Homo sapiens (Human))
Millennium Pharmaceuticals, Inc.
US Patent
Millennium Pharmaceuticals, Inc.
US Patent
Affinity DataIC50: 10nMAssay Description:The UAE enzymatic reaction totals 50 μL and contains 50 mmol HEPES (pH 7.5), 0.05% BSA, 2.5 mM MgCl2, 0.1 uM ATP, 8 nM GST-Ubc-2, 35 nM flag-ubi...More data for this Ligand-Target Pair
TargetUbiquitin-like modifier-activating enzyme 1(Homo sapiens (Human))
Millennium Pharmaceuticals, Inc.
US Patent
Millennium Pharmaceuticals, Inc.
US Patent
Affinity DataIC50: 10nMAssay Description:The UAE enzymatic reaction totals 50 μL and contains 50 mmol HEPES (pH 7.5), 0.05% BSA, 2.5 mM MgCl2, 0.1 uM ATP, 8 nM GST-Ubc-2, 35 nM flag-ubi...More data for this Ligand-Target Pair
TargetUbiquitin-like modifier-activating enzyme 1(Homo sapiens (Human))
Millennium Pharmaceuticals, Inc.
US Patent
Millennium Pharmaceuticals, Inc.
US Patent
Affinity DataIC50: 10nMAssay Description:The UAE enzymatic reaction totals 50 μL and contains 50 mmol HEPES (pH 7.5), 0.05% BSA, 2.5 mM MgCl2, 0.1 uM ATP, 8 nM GST-Ubc-2, 35 nM flag-ubi...More data for this Ligand-Target Pair
TargetUbiquitin-like modifier-activating enzyme 1(Homo sapiens (Human))
Millennium Pharmaceuticals, Inc.
US Patent
Millennium Pharmaceuticals, Inc.
US Patent
Affinity DataIC50: 10nMAssay Description:The UAE enzymatic reaction totals 50 μL and contains 50 mmol HEPES (pH 7.5), 0.05% BSA, 2.5 mM MgCl2, 0.1 uM ATP, 8 nM GST-Ubc-2, 35 nM flag-ubi...More data for this Ligand-Target Pair
TargetUbiquitin-like modifier-activating enzyme 1(Homo sapiens (Human))
Millennium Pharmaceuticals, Inc.
US Patent
Millennium Pharmaceuticals, Inc.
US Patent
Affinity DataIC50: 10nMAssay Description:The UAE enzymatic reaction totals 50 μL and contains 50 mmol HEPES (pH 7.5), 0.05% BSA, 2.5 mM MgCl2, 0.1 uM ATP, 8 nM GST-Ubc-2, 35 nM flag-ubi...More data for this Ligand-Target Pair
TargetUbiquitin-like modifier-activating enzyme 1(Homo sapiens (Human))
Millennium Pharmaceuticals, Inc.
US Patent
Millennium Pharmaceuticals, Inc.
US Patent
Affinity DataIC50: 10nMAssay Description:The UAE enzymatic reaction totals 50 μL and contains 50 mmol HEPES (pH 7.5), 0.05% BSA, 2.5 mM MgCl2, 0.1 uM ATP, 8 nM GST-Ubc-2, 35 nM flag-ubi...More data for this Ligand-Target Pair
TargetUbiquitin-like modifier-activating enzyme 1(Homo sapiens (Human))
Millennium Pharmaceuticals, Inc.
US Patent
Millennium Pharmaceuticals, Inc.
US Patent
Affinity DataIC50: 10nMAssay Description:The UAE enzymatic reaction totals 50 μL and contains 50 mmol HEPES (pH 7.5), 0.05% BSA, 2.5 mM MgCl2, 0.1 uM ATP, 8 nM GST-Ubc-2, 35 nM flag-ubi...More data for this Ligand-Target Pair
TargetUbiquitin-like modifier-activating enzyme 1(Homo sapiens (Human))
Millennium Pharmaceuticals, Inc.
US Patent
Millennium Pharmaceuticals, Inc.
US Patent
Affinity DataIC50: 10nMAssay Description:The UAE enzymatic reaction totals 50 μL and contains 50 mmol HEPES (pH 7.5), 0.05% BSA, 2.5 mM MgCl2, 0.1 uM ATP, 8 nM GST-Ubc-2, 35 nM flag-ubi...More data for this Ligand-Target Pair
TargetUbiquitin-like modifier-activating enzyme 1(Homo sapiens (Human))
Millennium Pharmaceuticals, Inc.
US Patent
Millennium Pharmaceuticals, Inc.
US Patent
Affinity DataIC50: 10nMAssay Description:The UAE enzymatic reaction totals 50 μL and contains 50 mmol HEPES (pH 7.5), 0.05% BSA, 2.5 mM MgCl2, 0.1 uM ATP, 8 nM GST-Ubc-2, 35 nM flag-ubi...More data for this Ligand-Target Pair
TargetUbiquitin-like modifier-activating enzyme 1(Homo sapiens (Human))
Millennium Pharmaceuticals, Inc.
US Patent
Millennium Pharmaceuticals, Inc.
US Patent
Affinity DataIC50: 10nMAssay Description:The UAE enzymatic reaction totals 50 μL and contains 50 mmol HEPES (pH 7.5), 0.05% BSA, 2.5 mM MgCl2, 0.1 uM ATP, 8 nM GST-Ubc-2, 35 nM flag-ubi...More data for this Ligand-Target Pair
TargetUbiquitin-like modifier-activating enzyme 1(Homo sapiens (Human))
Millennium Pharmaceuticals, Inc.
US Patent
Millennium Pharmaceuticals, Inc.
US Patent
Affinity DataIC50: 10nMAssay Description:The UAE enzymatic reaction totals 50 μL and contains 50 mmol HEPES (pH 7.5), 0.05% BSA, 2.5 mM MgCl2, 0.1 uM ATP, 8 nM GST-Ubc-2, 35 nM flag-ubi...More data for this Ligand-Target Pair
TargetUbiquitin-like modifier-activating enzyme 1(Homo sapiens (Human))
Millennium Pharmaceuticals, Inc.
US Patent
Millennium Pharmaceuticals, Inc.
US Patent
Affinity DataIC50: 10nMAssay Description:The UAE enzymatic reaction totals 50 μL and contains 50 mmol HEPES (pH 7.5), 0.05% BSA, 2.5 mM MgCl2, 0.1 uM ATP, 8 nM GST-Ubc-2, 35 nM flag-ubi...More data for this Ligand-Target Pair
TargetUbiquitin-like modifier-activating enzyme 1(Homo sapiens (Human))
Millennium Pharmaceuticals, Inc.
US Patent
Millennium Pharmaceuticals, Inc.
US Patent
Affinity DataIC50: 10nMAssay Description:The UAE enzymatic reaction totals 50 μL and contains 50 mmol HEPES (pH 7.5), 0.05% BSA, 2.5 mM MgCl2, 0.1 uM ATP, 8 nM GST-Ubc-2, 35 nM flag-ubi...More data for this Ligand-Target Pair
TargetUbiquitin-like modifier-activating enzyme 1(Homo sapiens (Human))
Millennium Pharmaceuticals, Inc.
US Patent
Millennium Pharmaceuticals, Inc.
US Patent
Affinity DataIC50: 10nMAssay Description:The UAE enzymatic reaction totals 50 μL and contains 50 mmol HEPES (pH 7.5), 0.05% BSA, 2.5 mM MgCl2, 0.1 uM ATP, 8 nM GST-Ubc-2, 35 nM flag-ubi...More data for this Ligand-Target Pair
TargetUbiquitin-like modifier-activating enzyme 1(Homo sapiens (Human))
Millennium Pharmaceuticals, Inc.
US Patent
Millennium Pharmaceuticals, Inc.
US Patent
Affinity DataIC50: 10nMAssay Description:The UAE enzymatic reaction totals 50 μL and contains 50 mmol HEPES (pH 7.5), 0.05% BSA, 2.5 mM MgCl2, 0.1 uM ATP, 8 nM GST-Ubc-2, 35 nM flag-ubi...More data for this Ligand-Target Pair
TargetUbiquitin-like modifier-activating enzyme 1(Homo sapiens (Human))
Millennium Pharmaceuticals, Inc.
US Patent
Millennium Pharmaceuticals, Inc.
US Patent
Affinity DataIC50: 10nMAssay Description:The UAE enzymatic reaction totals 50 μL and contains 50 mmol HEPES (pH 7.5), 0.05% BSA, 2.5 mM MgCl2, 0.1 uM ATP, 8 nM GST-Ubc-2, 35 nM flag-ubi...More data for this Ligand-Target Pair
TargetUbiquitin-like modifier-activating enzyme 1(Homo sapiens (Human))
Millennium Pharmaceuticals, Inc.
US Patent
Millennium Pharmaceuticals, Inc.
US Patent
Affinity DataIC50: 10nMAssay Description:The UAE enzymatic reaction totals 50 μL and contains 50 mmol HEPES (pH 7.5), 0.05% BSA, 2.5 mM MgCl2, 0.1 uM ATP, 8 nM GST-Ubc-2, 35 nM flag-ubi...More data for this Ligand-Target Pair
TargetUbiquitin-like modifier-activating enzyme 1(Homo sapiens (Human))
Millennium Pharmaceuticals, Inc.
US Patent
Millennium Pharmaceuticals, Inc.
US Patent
Affinity DataIC50: 10nMAssay Description:The UAE enzymatic reaction totals 50 μL and contains 50 mmol HEPES (pH 7.5), 0.05% BSA, 2.5 mM MgCl2, 0.1 uM ATP, 8 nM GST-Ubc-2, 35 nM flag-ubi...More data for this Ligand-Target Pair
TargetUbiquitin-like modifier-activating enzyme 1(Homo sapiens (Human))
Millennium Pharmaceuticals, Inc.
US Patent
Millennium Pharmaceuticals, Inc.
US Patent
Affinity DataIC50: 10nMAssay Description:The UAE enzymatic reaction totals 50 μL and contains 50 mmol HEPES (pH 7.5), 0.05% BSA, 2.5 mM MgCl2, 0.1 uM ATP, 8 nM GST-Ubc-2, 35 nM flag-ubi...More data for this Ligand-Target Pair
TargetUbiquitin-like modifier-activating enzyme 1(Homo sapiens (Human))
Millennium Pharmaceuticals, Inc.
US Patent
Millennium Pharmaceuticals, Inc.
US Patent
Affinity DataIC50: 10nMAssay Description:The UAE enzymatic reaction totals 50 μL and contains 50 mmol HEPES (pH 7.5), 0.05% BSA, 2.5 mM MgCl2, 0.1 uM ATP, 8 nM GST-Ubc-2, 35 nM flag-ubi...More data for this Ligand-Target Pair
TargetUbiquitin-like modifier-activating enzyme 1(Homo sapiens (Human))
Millennium Pharmaceuticals, Inc.
US Patent
Millennium Pharmaceuticals, Inc.
US Patent
Affinity DataIC50: 10nMAssay Description:The UAE enzymatic reaction totals 50 μL and contains 50 mmol HEPES (pH 7.5), 0.05% BSA, 2.5 mM MgCl2, 0.1 uM ATP, 8 nM GST-Ubc-2, 35 nM flag-ubi...More data for this Ligand-Target Pair
TargetUbiquitin-like modifier-activating enzyme 1(Homo sapiens (Human))
Millennium Pharmaceuticals, Inc.
US Patent
Millennium Pharmaceuticals, Inc.
US Patent
Affinity DataIC50: 10nMAssay Description:The UAE enzymatic reaction totals 50 μL and contains 50 mmol HEPES (pH 7.5), 0.05% BSA, 2.5 mM MgCl2, 0.1 uM ATP, 8 nM GST-Ubc-2, 35 nM flag-ubi...More data for this Ligand-Target Pair
TargetUbiquitin-like modifier-activating enzyme 1(Homo sapiens (Human))
Millennium Pharmaceuticals, Inc.
US Patent
Millennium Pharmaceuticals, Inc.
US Patent
Affinity DataIC50: 10nMAssay Description:The UAE enzymatic reaction totals 50 μL and contains 50 mmol HEPES (pH 7.5), 0.05% BSA, 2.5 mM MgCl2, 0.1 uM ATP, 8 nM GST-Ubc-2, 35 nM flag-ubi...More data for this Ligand-Target Pair
TargetUbiquitin-like modifier-activating enzyme 1(Homo sapiens (Human))
Millennium Pharmaceuticals, Inc.
US Patent
Millennium Pharmaceuticals, Inc.
US Patent
Affinity DataIC50: 10nMAssay Description:The UAE enzymatic reaction totals 50 μL and contains 50 mmol HEPES (pH 7.5), 0.05% BSA, 2.5 mM MgCl2, 0.1 uM ATP, 8 nM GST-Ubc-2, 35 nM flag-ubi...More data for this Ligand-Target Pair
TargetUbiquitin-like modifier-activating enzyme 1(Homo sapiens (Human))
Millennium Pharmaceuticals, Inc.
US Patent
Millennium Pharmaceuticals, Inc.
US Patent
Affinity DataIC50: 10nMAssay Description:The UAE enzymatic reaction totals 50 μL and contains 50 mmol HEPES (pH 7.5), 0.05% BSA, 2.5 mM MgCl2, 0.1 uM ATP, 8 nM GST-Ubc-2, 35 nM flag-ubi...More data for this Ligand-Target Pair
TargetUbiquitin-like modifier-activating enzyme 1(Homo sapiens (Human))
Millennium Pharmaceuticals, Inc.
US Patent
Millennium Pharmaceuticals, Inc.
US Patent
Affinity DataIC50: 10nMAssay Description:The UAE enzymatic reaction totals 50 μL and contains 50 mmol HEPES (pH 7.5), 0.05% BSA, 2.5 mM MgCl2, 0.1 uM ATP, 8 nM GST-Ubc-2, 35 nM flag-ubi...More data for this Ligand-Target Pair
TargetUbiquitin-like modifier-activating enzyme 1(Homo sapiens (Human))
Millennium Pharmaceuticals, Inc.
US Patent
Millennium Pharmaceuticals, Inc.
US Patent
Affinity DataIC50: 10nMAssay Description:The UAE enzymatic reaction totals 50 μL and contains 50 mmol HEPES (pH 7.5), 0.05% BSA, 2.5 mM MgCl2, 0.1 uM ATP, 8 nM GST-Ubc-2, 35 nM flag-ubi...More data for this Ligand-Target Pair
TargetUbiquitin-like modifier-activating enzyme 1(Homo sapiens (Human))
Millennium Pharmaceuticals, Inc.
US Patent
Millennium Pharmaceuticals, Inc.
US Patent
Affinity DataIC50: 10nMAssay Description:The UAE enzymatic reaction totals 50 μL and contains 50 mmol HEPES (pH 7.5), 0.05% BSA, 2.5 mM MgCl2, 0.1 uM ATP, 8 nM GST-Ubc-2, 35 nM flag-ubi...More data for this Ligand-Target Pair
TargetUbiquitin-like modifier-activating enzyme 1(Homo sapiens (Human))
Millennium Pharmaceuticals, Inc.
US Patent
Millennium Pharmaceuticals, Inc.
US Patent
Affinity DataIC50: 10nMAssay Description:The UAE enzymatic reaction totals 50 μL and contains 50 mmol HEPES (pH 7.5), 0.05% BSA, 2.5 mM MgCl2, 0.1 uM ATP, 8 nM GST-Ubc-2, 35 nM flag-ubi...More data for this Ligand-Target Pair
TargetUbiquitin-like modifier-activating enzyme 1(Homo sapiens (Human))
Millennium Pharmaceuticals, Inc.
US Patent
Millennium Pharmaceuticals, Inc.
US Patent
Affinity DataIC50: 10nMAssay Description:The UAE enzymatic reaction totals 50 μL and contains 50 mmol HEPES (pH 7.5), 0.05% BSA, 2.5 mM MgCl2, 0.1 uM ATP, 8 nM GST-Ubc-2, 35 nM flag-ubi...More data for this Ligand-Target Pair
TargetUbiquitin-like modifier-activating enzyme 1(Homo sapiens (Human))
Millennium Pharmaceuticals, Inc.
US Patent
Millennium Pharmaceuticals, Inc.
US Patent
Affinity DataIC50: 10nMAssay Description:The UAE enzymatic reaction totals 50 μL and contains 50 mmol HEPES (pH 7.5), 0.05% BSA, 2.5 mM MgCl2, 0.1 uM ATP, 8 nM GST-Ubc-2, 35 nM flag-ubi...More data for this Ligand-Target Pair
TargetUbiquitin-like modifier-activating enzyme 1(Homo sapiens (Human))
Millennium Pharmaceuticals, Inc.
US Patent
Millennium Pharmaceuticals, Inc.
US Patent
Affinity DataIC50: 10nMAssay Description:The UAE enzymatic reaction totals 50 μL and contains 50 mmol HEPES (pH 7.5), 0.05% BSA, 2.5 mM MgCl2, 0.1 uM ATP, 8 nM GST-Ubc-2, 35 nM flag-ubi...More data for this Ligand-Target Pair
TargetUbiquitin-like modifier-activating enzyme 1(Homo sapiens (Human))
Millennium Pharmaceuticals, Inc.
US Patent
Millennium Pharmaceuticals, Inc.
US Patent
Affinity DataIC50: 10nMAssay Description:The UAE enzymatic reaction totals 50 μL and contains 50 mmol HEPES (pH 7.5), 0.05% BSA, 2.5 mM MgCl2, 0.1 uM ATP, 8 nM GST-Ubc-2, 35 nM flag-ubi...More data for this Ligand-Target Pair
TargetUbiquitin-like modifier-activating enzyme 1(Homo sapiens (Human))
Millennium Pharmaceuticals, Inc.
US Patent
Millennium Pharmaceuticals, Inc.
US Patent
Affinity DataIC50: 10nMAssay Description:The UAE enzymatic reaction totals 50 μL and contains 50 mmol HEPES (pH 7.5), 0.05% BSA, 2.5 mM MgCl2, 0.1 uM ATP, 8 nM GST-Ubc-2, 35 nM flag-ubi...More data for this Ligand-Target Pair
TargetUbiquitin-like modifier-activating enzyme 1(Homo sapiens (Human))
Millennium Pharmaceuticals, Inc.
US Patent
Millennium Pharmaceuticals, Inc.
US Patent
Affinity DataIC50: 10nMAssay Description:The UAE enzymatic reaction totals 50 μL and contains 50 mmol HEPES (pH 7.5), 0.05% BSA, 2.5 mM MgCl2, 0.1 uM ATP, 8 nM GST-Ubc-2, 35 nM flag-ubi...More data for this Ligand-Target Pair
TargetUbiquitin-like modifier-activating enzyme 1(Homo sapiens (Human))
Millennium Pharmaceuticals, Inc.
US Patent
Millennium Pharmaceuticals, Inc.
US Patent
Affinity DataIC50: 10nMAssay Description:The UAE enzymatic reaction totals 50 μL and contains 50 mmol HEPES (pH 7.5), 0.05% BSA, 2.5 mM MgCl2, 0.1 uM ATP, 8 nM GST-Ubc-2, 35 nM flag-ubi...More data for this Ligand-Target Pair
TargetUbiquitin-like modifier-activating enzyme 1(Homo sapiens (Human))
Millennium Pharmaceuticals, Inc.
US Patent
Millennium Pharmaceuticals, Inc.
US Patent
Affinity DataIC50: 10nMAssay Description:The UAE enzymatic reaction totals 50 μL and contains 50 mmol HEPES (pH 7.5), 0.05% BSA, 2.5 mM MgCl2, 0.1 uM ATP, 8 nM GST-Ubc-2, 35 nM flag-ubi...More data for this Ligand-Target Pair
TargetUbiquitin-like modifier-activating enzyme 1(Homo sapiens (Human))
Millennium Pharmaceuticals, Inc.
US Patent
Millennium Pharmaceuticals, Inc.
US Patent
Affinity DataIC50: 10nMAssay Description:The UAE enzymatic reaction totals 50 μL and contains 50 mmol HEPES (pH 7.5), 0.05% BSA, 2.5 mM MgCl2, 0.1 uM ATP, 8 nM GST-Ubc-2, 35 nM flag-ubi...More data for this Ligand-Target Pair
TargetUbiquitin-like modifier-activating enzyme 1(Homo sapiens (Human))
Millennium Pharmaceuticals, Inc.
US Patent
Millennium Pharmaceuticals, Inc.
US Patent
Affinity DataIC50: 10nMAssay Description:The UAE enzymatic reaction totals 50 μL and contains 50 mmol HEPES (pH 7.5), 0.05% BSA, 2.5 mM MgCl2, 0.1 uM ATP, 8 nM GST-Ubc-2, 35 nM flag-ubi...More data for this Ligand-Target Pair
TargetUbiquitin-like modifier-activating enzyme 1(Homo sapiens (Human))
Millennium Pharmaceuticals, Inc.
US Patent
Millennium Pharmaceuticals, Inc.
US Patent
Affinity DataIC50: 10nMAssay Description:The UAE enzymatic reaction totals 50 μL and contains 50 mmol HEPES (pH 7.5), 0.05% BSA, 2.5 mM MgCl2, 0.1 uM ATP, 8 nM GST-Ubc-2, 35 nM flag-ubi...More data for this Ligand-Target Pair
TargetUbiquitin-like modifier-activating enzyme 1(Homo sapiens (Human))
Millennium Pharmaceuticals, Inc.
US Patent
Millennium Pharmaceuticals, Inc.
US Patent
Affinity DataIC50: 10nMAssay Description:The UAE enzymatic reaction totals 50 μL and contains 50 mmol HEPES (pH 7.5), 0.05% BSA, 2.5 mM MgCl2, 0.1 uM ATP, 8 nM GST-Ubc-2, 35 nM flag-ubi...More data for this Ligand-Target Pair
TargetUbiquitin-like modifier-activating enzyme 1(Homo sapiens (Human))
Millennium Pharmaceuticals, Inc.
US Patent
Millennium Pharmaceuticals, Inc.
US Patent
Affinity DataIC50: 10nMAssay Description:The UAE enzymatic reaction totals 50 μL and contains 50 mmol HEPES (pH 7.5), 0.05% BSA, 2.5 mM MgCl2, 0.1 uM ATP, 8 nM GST-Ubc-2, 35 nM flag-ubi...More data for this Ligand-Target Pair
TargetUbiquitin-like modifier-activating enzyme 1(Homo sapiens (Human))
Millennium Pharmaceuticals, Inc.
US Patent
Millennium Pharmaceuticals, Inc.
US Patent
Affinity DataIC50: 10nMAssay Description:The UAE enzymatic reaction totals 50 μL and contains 50 mmol HEPES (pH 7.5), 0.05% BSA, 2.5 mM MgCl2, 0.1 uM ATP, 8 nM GST-Ubc-2, 35 nM flag-ubi...More data for this Ligand-Target Pair
TargetUbiquitin-like modifier-activating enzyme 1(Homo sapiens (Human))
Millennium Pharmaceuticals, Inc.
US Patent
Millennium Pharmaceuticals, Inc.
US Patent
Affinity DataIC50: 10nMAssay Description:The UAE enzymatic reaction totals 50 μL and contains 50 mmol HEPES (pH 7.5), 0.05% BSA, 2.5 mM MgCl2, 0.1 uM ATP, 8 nM GST-Ubc-2, 35 nM flag-ubi...More data for this Ligand-Target Pair
TargetUbiquitin-like modifier-activating enzyme 1(Homo sapiens (Human))
Millennium Pharmaceuticals, Inc.
US Patent
Millennium Pharmaceuticals, Inc.
US Patent
Affinity DataIC50: 10nMAssay Description:The UAE enzymatic reaction totals 50 μL and contains 50 mmol HEPES (pH 7.5), 0.05% BSA, 2.5 mM MgCl2, 0.1 uM ATP, 8 nM GST-Ubc-2, 35 nM flag-ubi...More data for this Ligand-Target Pair
TargetUbiquitin-like modifier-activating enzyme 1(Homo sapiens (Human))
Millennium Pharmaceuticals, Inc.
US Patent
Millennium Pharmaceuticals, Inc.
US Patent
Affinity DataIC50: 10nMAssay Description:The UAE enzymatic reaction totals 50 μL and contains 50 mmol HEPES (pH 7.5), 0.05% BSA, 2.5 mM MgCl2, 0.1 uM ATP, 8 nM GST-Ubc-2, 35 nM flag-ubi...More data for this Ligand-Target Pair
TargetUbiquitin-like modifier-activating enzyme 1(Homo sapiens (Human))
Millennium Pharmaceuticals, Inc.
US Patent
Millennium Pharmaceuticals, Inc.
US Patent
Affinity DataIC50: 10nMAssay Description:The UAE enzymatic reaction totals 50 μL and contains 50 mmol HEPES (pH 7.5), 0.05% BSA, 2.5 mM MgCl2, 0.1 uM ATP, 8 nM GST-Ubc-2, 35 nM flag-ubi...More data for this Ligand-Target Pair
TargetUbiquitin-like modifier-activating enzyme 1(Homo sapiens (Human))
Millennium Pharmaceuticals, Inc.
US Patent
Millennium Pharmaceuticals, Inc.
US Patent
Affinity DataIC50: 10nMAssay Description:The UAE enzymatic reaction totals 50 μL and contains 50 mmol HEPES (pH 7.5), 0.05% BSA, 2.5 mM MgCl2, 0.1 uM ATP, 8 nM GST-Ubc-2, 35 nM flag-ubi...More data for this Ligand-Target Pair
TargetUbiquitin-like modifier-activating enzyme 1(Homo sapiens (Human))
Millennium Pharmaceuticals, Inc.
US Patent
Millennium Pharmaceuticals, Inc.
US Patent
Affinity DataIC50: 10nMAssay Description:The UAE enzymatic reaction totals 50 μL and contains 50 mmol HEPES (pH 7.5), 0.05% BSA, 2.5 mM MgCl2, 0.1 uM ATP, 8 nM GST-Ubc-2, 35 nM flag-ubi...More data for this Ligand-Target Pair
